XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Income Statement [Abstract]        
Service revenue, net $ 899 $ 316 $ 1,690 $ 619
Clinical research grants 62   62  
Other (2)   3  
Revenue, net of contractual allowances and adjustments 959 316 1,755 619
less allowance for doubtful accounts (142) (56) (226) (111)
Net sales 817 260 1,529 508
Service revenues 585 284 1,273 466
Clinical research grants 57   57  
Total cost of sales 642 284 1,330 466
Gross profit 175 (24) 199 42
OPERATING EXPENSES:        
Operating expenses 2,358 777 4,536 1,440
Impairment of goodwill 0   294  
TOTAL OPERATING EXPENSES 2,358 777 4,830 1,440
OPERATING LOSS (2,183) (801) (4,631) (1,398)
OTHER INCOME (EXPENSE):        
Interest expense, net (48) (220) (56) (382)
Warrant revaluation 323 (3) 584 (3)
Derivative revaluation (1)   (1)  
Gain on settlement liability, net 6   147  
Loss on extinguisment of debt   (53)   (53)
Loss on issuance of convertible notes (928)   (928)  
Merger advisory fees   (2,603)   (2,603)
Loss on settlement of equity instrument     (385)  
Total other nonoperating income (expense) (648) (2,879) (639) (3,041)
LOSS BEFORE INCOME TAXES (2,831) (3,680) (5,270) (4,439)
INCOME TAX EXPENSE 0 0 0 0
NET LOSS (2,831) (3,680) (5,270) (4,439)
Deemed dividends related to beneficial conversion feature of preferred stock and fair value of consideration issued to induce conversion of preferred stock (334) (5,248) (3,848) (5,248)
TOTAL DIVIDENDS (334) (5,248) (3,848) (5,248)
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS $ (3,165) $ (8,928) $ (9,118) $ (9,687)
BASIC AND DILUTED LOSS PER COMMON SHARE (IN DOLLARS PER SHARE) $ (0.15) $ (15.35) $ (0.55) $ (18.77)
BASIC AND DILUTED WEIGHTED-AVERAGE SHARES OF COMMON STOCK OUTSTANDING (IN SHARES) 20,737,789 581,481 16,679,459 515,968